Évolution du taux de PSA après administration de 177Lu-PSMA dans les cancers de prostate

Médecine Nucléaire 2026

View at publisher

Authors: F. El Fartass, Xavier Malezieux

DOI: 10.1016/j.mednuc.2026.01.138

Cited by: 0

Fields of Study & Subjects

Radiopharmaceutical Chemistry and Applications Prostate Cancer Treatment and Research Prostate Cancer Diagnosis and Treatment